Komfie Manalo, Opalesque Asia: The APS Japan Alpha Fund returned 0.86% in May compared to the TOPIX Net Index’s return of -0.70%, outperforming the benchmark by 1.56 percentage points. Year-to-date, the fund gained 1.77% gross, outperforming the index by 5.04 percentage points, reported Singapore-based fund management firm APS Asset Management Pte Ltd.
In its monthly report, APS Asset added that the APS Far East Alpha Fund returned -2.54% during the month compared to the MSCI Daily TR AC Far East ex Japan Index’s return of -1.68%, underperforming the index by 0.86 percentage points.
The APS China A Share Fund outperformed the customized benchmark by 1.85 percentage points in the month, while the APS Asia Pacific Long Short (Cayman) Fund and the APS Greater China Long/Short Fund registered net returns of 0.15% and -0.68% respectively in May.
APS said in its report, "We continued to expect market volatility due to the distractions of macro policies. In this environment, our investment strategy remained constant and we stayed focused on structural alpha stocks such as innovative pharma and cybersecurity companies."
Gains from pharma and cybersecurity
It added that among the top contributors in May was Nippon Shinyaku, a pharmaceutical company producing the innovative drug Uptravi for the treatment of pulmonary artery hypertension. In May, Swiss-based Roche announced that the phase three trial of ...................... To view our full article Click here
|